CytoDyn Inc. (CYDY) › Cash & EquivalentsCytoDyn Inc. (CYDY) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2003: $3.2K2010: $700.5K2011: $1.04M2012: $285.0K2013: $603.7K2014: $4.89M2015: $1.05M2016: $9.64M2017: $1.78M2018: $1.23M2019: $2.61M2020: $14.28M2021: $33.94M2022: $4.23M2023: $2.54M2024: $3.11M2025: $11.90M$11.90M2003Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$11.90M+282.7%2024$3.11M+22.4%2023$2.54M-39.9%2022$4.23M-87.5%2021$33.94M+137.7%2020$14.28M+446.6%2019$2.61M+112.2%2018$1.23M-30.6%2017$1.78M-81.6%2016$9.64M+818.2%2015$1.05M-78.5%2014$4.89M+709.4%2013$603.7K+111.8%2012$285.0K-72.5%2011$1.04M+48.2%2010$700.5K—2003$3.2K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share